<p>We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.</p>

We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.

EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Share EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD

Sign up to save your podcasts

EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD

EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD

More shows like Retina Synthesis

Straight From The Cutter's Mouth: A Retina Podcast